Versant Venture Capital Vi, L.P. is of Graphite Bio, Inc.. Currently has a direct ownership of 14.7 Million shares of GRPH, which is worth approximately $0. The most recent transaction as insider was on Jun 29, 2021, when has been sold 12,343,727 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.7M
0% 3M change
0% 12M change
Total Value Held $0

Versant Venture Capital VI, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 29 2021
BUY
Conversion of derivative security
-
12,343,727 Added 45.63%
14,708,398 Common Stock

Also insider at

BDTX
Black Diamond Therapeutics, Inc. Healthcare
ALGS
Aligos Therapeutics, Inc. Healthcare
OYST
Oyster Point Pharma, Inc. Healthcare
IPSC
Century Therapeutics, Inc. Healthcare
GLUE
Monte Rosa Therapeutics, Inc. Healthcare
CTNM
Contineum Therapeutics, Inc.
TPST
Tempest Therapeutics, Inc. Healthcare
VVC

Versant Venture Capital Vi, L.P.

San Francisco, CA

Track Institutional and Insider Activities on GRPH

Follow Graphite Bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GRPH shares.

Notify only if

Insider Trading

Get notified when an Graphite Bio, Inc. insider buys or sells GRPH shares.

Notify only if

News

Receive news related to Graphite Bio, Inc.

Track Activities on GRPH